We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Orthofix International N.V. announced that it has completed its acquisition of Blackstone Medical, which was originally announced on August 7th of this year.
Eye care company Bausch & Lomb said Wednesday it will cut 400 jobs, most of them temporary slots, as part of an adjustment to its workforces throughout Europe and the U.S. BOL said it had hired temporary workers to ramp up production of its PureVision contact lens.
Plethora Solutions Holdings announced it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its SAM device (PSD401).
Cordis Endovascular, a division of Cordis, Sept. 26 announced it has received approval from the Food and Drug Administration (FDA) to market its PRECISE Nitinol Stent and ANGIOGUARD Emboli Capture Guidewire to treat clogged neck arteries, known as carotid artery disease.
According to a report released earlier this month, the number of patients in the United States with diseases that are potentially treatable with neurodevices is currently 78 million, or about 28% of the total population.
In response to the Centers for Medicare & Medicaid Services (CMS) recently issuing information on Medicare mobility benefits and a revision of its local coverage determination (LCD) for power mobility devices, Mike Pfister, president of The Scooter Store, made several recommendations.
AdvaMed announced Sept. 25 it had joined an alliance of patient groups, consumer advocates, public health organizations and companies focused on building public support for the FDA.
Recent findings suggest that manufacturers of pacemakers and implantable cardioverter-defibrillators (ICDs) can make their products safe for patients who undergo magnetic resonance imaging (MRI) scans, a researcher said.
A technology that manipulates molecules is being used to manufacture synthetic bone, with applications in the sports medicine, trauma, spine, and general orthopedics markets.